NASDAQ · SCNI
Scinai Immunotherapeutics Ltd.
Latest quarter · ended Mar 31, 2023
Cash got weaker
Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.
Smart money pulse
What insiders and funds are doing
- infoNo real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.
−100 means everyone selling, +100 everyone buying. This is data, not advice.
How the Pulse works
Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.
Who owns it
11 funds report owning SCNI, up from 4
Insider trades · last 12 months
Real buys and sales
No open-market buys or sales by officers or directors in the last 12 months. Hidden: 2 stock grants. Press All filings to see them.
Last 6 months. A wider screen shows 12.
Showing 0 real trades. Hidden: 2 stock grants. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.
Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.
Top holders
Biggest funds in SCNI
| Fund | Owns | Value | Change |
|---|---|---|---|
| Citadel Advisors LLC | <0.1% | $15.7K | New |
| Armistice Capital, LLC | <0.1% | $9.08K | New |
| Virtu Financial LLC | <0.1% | $5K | New |
| StoneX Group Inc. | <0.1% | $4.56K | New |
| XTX Topco Ltd | <0.1% | $4.24K | −77% |
"Owns" is shares reported divided by shares outstanding.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.